ICON Public (NASDAQ:ICLR) Releases FY24 Earnings Guidance

ICON Public (NASDAQ:ICLRGet Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $14.65-$15.15 for the period, compared to the consensus earnings per share estimate of $14.94. The company issued revenue guidance of $8.48-$8.72 billion, compared to the consensus revenue estimate of $8.64 billion.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on ICLR. Barclays lifted their target price on shares of ICON Public from $325.00 to $355.00 and gave the stock an overweight rating in a report on Friday, February 23rd. Mizuho restated a buy rating and issued a $346.00 price target on shares of ICON Public in a research report on Thursday, April 4th. Evercore ISI raised their price target on shares of ICON Public from $325.00 to $350.00 and gave the stock an outperform rating in a research report on Friday, February 23rd. Robert W. Baird raised their price target on shares of ICON Public from $345.00 to $362.00 and gave the stock an outperform rating in a research report on Thursday, April 4th. Finally, Truist Financial raised their price target on shares of ICON Public from $357.00 to $367.00 and gave the stock a buy rating in a research report on Friday, February 23rd. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, ICON Public presently has an average rating of Moderate Buy and an average price target of $319.45.

Check Out Our Latest Report on ICON Public

ICON Public Price Performance

NASDAQ:ICLR traded down $8.90 on Thursday, reaching $300.54. The stock had a trading volume of 697,926 shares, compared to its average volume of 558,183. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.40. The company has a market capitalization of $24.79 billion, a P/E ratio of 40.71, a price-to-earnings-growth ratio of 1.45 and a beta of 1.15. The stock has a fifty day moving average price of $317.97 and a 200-day moving average price of $282.01. ICON Public has a 1-year low of $181.92 and a 1-year high of $344.77.

ICON Public (NASDAQ:ICLRGet Free Report) last announced its quarterly earnings results on Wednesday, February 21st. The medical research company reported $3.40 earnings per share for the quarter, topping analysts’ consensus estimates of $3.27 by $0.13. ICON Public had a net margin of 7.54% and a return on equity of 11.42%. The company had revenue of $2.07 billion for the quarter, compared to analysts’ expectations of $2.08 billion. Research analysts forecast that ICON Public will post 14.4 EPS for the current year.

ICON Public Company Profile

(Get Free Report)

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

Further Reading

Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.